Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC49H43ClN10O10S3 |
InChIKeyKYDDRMSTHXFLJE-IFTPUMMRSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | SG | 02 Dec 2022 |